Florida Surgeon General Joseph A. Ladopo shredded the Biden administration’s Secretary of Health and Human Services, Xavier Becerra, in a letter accusing the Biden administration of a highly effective alternative COVID-19 treatment.
Ladopo said in his Tuesday letter that the Biden admin is “actively preventing the effective distribution of monoclonal antibody treatments in the U.S.”
Ladopo pointed out that in August, Florida GOP governor Ron DeSantis had “announced a rapid increase in the availability of monoclonal antibody therapy treatments across the state,” adding, “In a matter of weeks, the state had 25 monoclonal antibody sites up and running – leading the nation in widespread early COVID-19 treatment availability.”
“By mid-September, the State of Florida provided this life-saving treatment to nearly 100,000 patients,” he continued. “These sites served 5,000 patients a day at the peak and nearly 30,000 per week. Florida pioneered monoclonal antibodies as a statewide solution to prevent severe illness and reduce the strain of COVID-19 on the state’s hospital systems.”
Ladopo noted that soon after Florida had reached 100,000 people with their monoclonal antibody treatments, HHS “announced a dramatic reduction in the number of monoclonal antibodies to be allocated to the State of Florida.” He recalled, “Governor DeSantis moved quickly to acquire Sotrovimab from GlaxoSmithKline to help alleviate the artificial shortage caused by this sudden shift from HHS.“
“The federal government is actively preventing the effective distribution of monoclonal antibody treatments in the U.S.,” Ladopo alleged. “The sudden suspension of multiple monoclonal antibody therapy treatments from distribution to Florida removes a health care provider’s ability to decide the best treatment options for their patients in this state. This shortsightedness is especially evident given that the federal government effectively prohibited states from purchasing these monoclonal antibodies and serving their populations directly.”
The Biden administration claimed in September that it was cutting shipments of the treatments to seven states, including Florida, because those states were using 70% of the nation’s supply, WFLA reported.
Now, the Biden administration has reportedly paused shipments of COVID-19 antibody treatments manufactured by major drug companies Regeneron and Eli Lilly – claiming that such treatments are not effective against the omicron variant which is basically just a cold and certainly not the only prevalent variant.
Ladopo continued in his letter, “Florida is a large, diverse state with one of the highest percentages of seniors in the U.S., and we must empower healthcare providers to make decisions that will save the lives of Americans everywhere without the dictates imposed by the federal government.”
“President Biden recently stated that there is no federal solution to COVID-19, and solving this pandemic will happen at the state level. Therefore, as Surgeon General, I respectfully respect that you allow states and healthcare practitioners to provide treatment options that best benefit the communities they know and serve.”
The restriction of the highly effective monoclonal antibody treatment could be yet another sick attempt by the Biden administration to coerce Americans into getting vaccinated by leaving them no other choice for treatment.
Author: Jesse Friedmore
These content links are provided by Content.ad. Both Content.ad and the web site upon which the links are displayed may receive compensation when readers click on these links. Some of the content you are redirected to may be sponsored content. View our privacy policy here.
To learn how you can use Content.ad to drive visitors to your content or add this service to your site, please contact us at [email protected].
Family-Friendly Content
Website owners select the type of content that appears in our units. However, if you would like to ensure that Content.ad always displays family-friendly content on this device, regardless of what site you are on, check the option below. Learn More
These content links are provided by Content.ad. Both Content.ad and the web site upon which the links are displayed may receive compensation when readers click on these links. Some of the content you are redirected to may be sponsored content. View our privacy policy here.
To learn how you can use Content.ad to drive visitors to your content or add this service to your site, please contact us at [email protected].
Family-Friendly Content
Website owners select the type of content that appears in our units. However, if you would like to ensure that Content.ad always displays family-friendly content on this device, regardless of what site you are on, check the option below. Learn More
